期刊文献+

肌动蛋白凝胶蛋白在胃癌组织中的表达及临床意义 被引量:6

Expression and clinicopathological analysis of transgelin in gastric cancer
原文传递
导出
摘要 目的 探讨肌动蛋白凝胶蛋白(Transgelin)在胃癌组织及癌旁组织中的表达差异及其临床意义.方法 应用免疫组织化学方法测定癌组织及癌旁组织中Transgelin的表达,分析其与临床病理特征的关系.结果 Transgelin在胃腺癌中高表达率为55.56% (70/126),高于癌旁组织的44.44% (56/126),差异有统计学意义(Z=-7.264,P<0.01).胃腺癌组织中Transgelin的高表达与患者的年龄、性别、TNM分期、远处转移、分化类型、浸润深度及组织类型无明显相关(P>0.05),但与患者的的淋巴结转移、肿瘤大小和5年生存期明显相关(P<0.05).结论 Transgelin的高表达与胃癌的发生发展相关. Objective To investigate the expression level and the clinical significance of Transgelin on gastric adenocarcinomas tissues and paired non-neoplastic tissues.Methods The express of Transgelin was detected by using immunohistochemistry,and the relationship Transgelin level with clinicopathogical factors was explored.Results The positive expression of Transgelin was in cancer tissues was 55.56% (70/126),higher than 44.44% (56/126),compared to the levels in non-neoplastic tissues P 〈 0.05 (the Wilcoxon test).Up-expression of Transgelin was not correlated with patients' age,nor with sex,TNM stage,distant metastasis,differentiation grade,the depth of invasion and tissue type,but related with lymphnode metastasis (P 〈 0.05),tumor size (P 〈 0.05) and 5-years survival of patients (P 〈 0.01).Conclusion Transgelin may play important roles in the development and progression of gastric carcinoma.
出处 《中华实验外科杂志》 CAS CSCD 北大核心 2016年第5期1339-1341,共3页 Chinese Journal of Experimental Surgery
关键词 胃腺癌 肌动蛋白凝胶蛋白 免疫组织化学法 Gastric adenocarcinomas Transgelin Immunohistochemistry
  • 相关文献

参考文献5

二级参考文献45

  • 1Duffy MJ. Clinical uses of tumor markers: a critical review. Crit Rev Clin Lab Sci 2001; 38:225-262. 被引量:1
  • 2Thomas CM, Sweep CG. Serum tumor markers: past, state of the art, and future, lnt J Biol Markers 2001; 16:73-86. 被引量:1
  • 3Duffy MJ. Role of tumor markers in patients with solid cancers: a critical review. Eur J lntern Med 2007; 18:175-184. 被引量:1
  • 4Roulston JE. Limitations of tumour markers in screening. Br J Surg 1990; 77:961-962. 被引量:1
  • 5Esquela-Kerscher A, Slack FJ. Oncomirs - microRNAs with a role in cancer. Nat Rev Cancer 2006; 6:259-269. 被引量:1
  • 6Calin GA, Croce CM. MicroRNA signatures in human cancers. Nat Rev Cancer 2006; 6:857-866. 被引量:1
  • 7Chen C, Ridzon DA, Broomer A J, et al. Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Res 2005; 33:e179. 被引量:1
  • 8Tang F, Hajkova P, Barton SC, Lao K, Surani MA. MicroRNA expression profiling of single whole embryonic stem cells. Nucleic Acids Res 2006; 34:e9. 被引量:1
  • 9Hafner M, Landgraf P, Ludwig J, et al. Identification of microRNAs and other small regulatory RNAs using cDNA library sequencing. Methods 2008; 44:3-12. 被引量:1
  • 10Volinia S, Calin GA, Liu CG, et al. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci USA 2006; 103:2257-2261. 被引量:1

共引文献1001

同被引文献24

引证文献6

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部